Skip to main content
. 2019 Aug 2;6(9):1659–1670. doi: 10.1002/acn3.50854

Table 1.

Baseline characteristics

Variable Overall (n = 1596) IGFBP‐2
T1 (n = 531)
IGFBP‐2
T2 (n = 533)
IGFBP‐2
T3 (n = 532)
No. (%)
Age, year, mean (SD) 68.7 (5.7) 66.7 (4.8) 68.4 (5.5) 71.0 (5.9)
Women 841 (52.7) 289 (54.4) 265 (49.7) 287 (54.0)
Systolic blood pressure, mmHg, mean (SD) 132.4 (19.2) 132.3 (17.3) 132.0 (19.6) 132.9 (20.6)
BMI, kg/m2, median (Q1, Q3) 28.1 (24.7, 30.9) 29.5 (26.7, 32.8) 27.5 (25.0, 30.8) 25.7 (23.2, 28.3)
IGFBP‐2, pg/mL, median (Q1, Q3) 1.2 × 107 (8.2 × 106, 1.8 × 107) 6.7 × 106 (5.3 × 106, 8.2 × 106 1.2 × 107 (1.1 × 107, 1.4 × 107 2.1 × 107 (1.8 × 107, 2.6 × 107)
Education
No high school degree 101 (6.5) 29 (5.7) 28 (5.4) 44 (8.5)
High school degree 525 (33.9) 182 (35.6) 168 (32.3) 175 (33.8)
Some years of college 450 (29.0) 145 (28.3) 151 (29.0) 154 (29.7)
College degree 475 (30.6) 156 (30.5) 174 (33.4) 145 (28.0)
Antihypertensive medication 700 (43.9) 240 (45.3) 230 (43.2) 230 (43.2)
Current smoker 135 (8.5) 27 (5.1) 47 (8.8) 61 (11.5)
Prevalent diabetes mellitus 262 (16.4) 114 (21.5) 84 (15.8) 64 (12.0)
ApoE4 allele 353 (22.4) 120 (23.1) 122 (23.0) 111 (21.2)
Prevalent CVD 302 (18.9) 73 (13.8) 97 (18.2) 132 (24.8)
Atrial fibrillation 94 (5.9) 23 (4.3) 37 (6.9) 34 (6.4)
Stroke 42 (2.6) 10 (1.9) 10 (1.9) 22 (4.1)

Baseline demographic and clinical characteristics were defined at examination 7. IGFBP‐2, insulin‐like growth factor binding protein‐2; SD, standard deviation; BMI, body mass index; CVD, cardiovascular disease; APOE E4, apolipoprotein E4 allele.